These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20836681)

  • 1. Radiotherapy for laryngeal squamous cell carcinoma: current standards.
    Dirix P; Lambrecht M; Nuyts S
    Expert Rev Anticancer Ther; 2010 Sep; 10(9):1461-9. PubMed ID: 20836681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State-of-the-art management of locally advanced head and neck cancer.
    Seiwert TY; Cohen EE
    Br J Cancer; 2005 Apr; 92(8):1341-8. PubMed ID: 15846296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
    Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT
    Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
    Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
    Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol.
    de Andrés L; Brunet J; López-Pousa A; Burgués J; Quer M; León X; Guedea F; Vega M; Mesía R; López JJ
    Laryngoscope; 1995 Aug; 105(8 Pt 1):822-6. PubMed ID: 7630294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG; Langer CJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of chemotherapy in squamous cell tumors of the larynx].
    Merlano M; Benasso M; Cavallari M; Muttini MP
    Acta Otorhinolaryngol Ital; 1991; 11 Suppl 33():129-34. PubMed ID: 1718139
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
    Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
    Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?
    Porceddu SV
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):75-6. PubMed ID: 20565417
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation.
    Wolf GT; Fisher SG
    Laryngoscope; 1992 Aug; 102(8):934-9. PubMed ID: 1495357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.
    Bidoli P; Bajetta E; Stani SC; De CD; Santoro A; Valente M; Zucali R; Valagussa P; Ravasi G; Bonadonna G
    Cancer; 2002 Jan; 94(2):352-61. PubMed ID: 11900221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
    Trask DK; Wolf GT; Bradford CR; Fisher SG; Devaney K; Johnson M; Singleton T; Wicha M
    Laryngoscope; 2002 Apr; 112(4):638-44. PubMed ID: 12150516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preservation of the larynx in advanced cancer--experiences at the Oncology Department, Rambam Medical Center, Haifa].
    Rosenblatt E; Siegelmann-Danieli N; Zidan J; Haim N; Kuten A
    Harefuah; 2000 Oct; 139(7-8):271-4, 326. PubMed ID: 11062969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
    Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
    Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of definitive radiation therapy for larynx preservation in patients with advanced laryngeal cancer.
    Keum KC; Kim GE; Suh CO; Lee JY; Roh JK; Kim KM; Kim YH; Hong WP
    J Otolaryngol; 1999 Oct; 28(5):245-51. PubMed ID: 10579152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
    Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Sanz-Ortiz J
    Laryngoscope; 2004 Jul; 114(7):1163-9. PubMed ID: 15235341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
    Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Kawakami M; Watanabe M; Niho T; Abo H; Yamomoto S
    Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.